Recent reports show that curdlan can inhibit TH2‐cell responses, promoting breast cancer progression 43; it was also reported to suppress IL‐5, IL‐13 and surprisingly IL‐1β from lymph nodes during epicutaneous sensitization 44. The gene discussed is IL1B; the disease is breast carcinoma.